James Kelly, CEO of Stem Cell Innovations, said: “We have been working for several years to develop a more effective method for producing stem cells from germ cells. This filing was submitted to secure our intellectual property prior to publication in the scientific literature.
“The method in this application provides for a substantial improvement in both the yield and quality of stem cells produced. It builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions.”